Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab.

In their analysis, the occurrence of lymphoma was rare and did not reach statistical significance. 3 Systematic review of the literature regarding the safety of disease-modifying antirheumatic drugs by Ramiro et al 13 found that patients on TNF inhibitors compared with patients on conventional drugs had a higher risk of serious infections, a higher risk of tuberculosis, and possibly an increased risk of infection by herpes zoster.

also in 111,027 other papers